Article Details
Retrieved on: 2022-04-05 10:23:11
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
A little-known antisense oligonucleotide, Astrazeneca/Ionis's AZD8233, has surprised in a mid-stage trial, showing cholesterol lowering well in ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here